In line with this observation, the combination of TRAIL and dinaciclib treatment failed to induce caspase-8 cleavage in H1694 SCLC cells, whereas it successfully did so in the NSCLC cell lines tested. This evidence concerns the gene CASP8 and small cell lung carcinoma.